Medication info
Trudapa Tablet 10 mg (Dapagliflozin Bis Proline)

Trudapa Tablet 10 mg (Dapagliflozin Bis Proline)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Bis L-proline›15.63mg / 1 tablet
Manufacturer / importer
Boryung Pharm. Co., Ltd.
Appearance
Yellow, biconvex, diamond-shaped film-coated tablet
Packaging
Bottle package - 30 tablets/bottle, bottle package - 100 tablets/bottle
Approval status
Active

MFDS item code 202003737 · Approved 2020.05.22 · Insurance code 641907990

Summary

Main use
Treatment of type 2 diabetes, chronic heart failure, and chronic kidney disease
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR below 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
Children under 18 years of age: The efficacy and safety of dapagliflozin have not been established. There are no relevant data.

Ingredients

Manufacturer
Boryung Pharm. Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes, chronic heart failure, and chronic kidney disease

  • Type 2 diabetes
  • poor glucose control
  • cardiovascular disease
  • cardiovascular risk factors
  • chronic heart failure
  • cardiovascular disease
  • heart failure
  • chronic kidney disease
  • decreased glomerular filtration rate
  • end-stage kidney disease
  • risk of kidney-related mortality
View approved original text

This medication is primarily used to improve glucose control in patients with type 2 diabetes. It is also administered together with other treatments to reduce the risk of death and hospitalization due to cardiovascular disease in patients with chronic heart failure. In chronic kidney disease patients, it is used to lower the risk of decreased glomerular filtration rate and kidney-related mortality. Thus, this drug works effectively to manage diabetes, heart failure, and kidney disease, providing assistance in managing each condition. Depending on the patient’s condition, it can be administered alone or in combination therapy; please refer to expert guidance for detailed information. This medication is used for overall glucose control and improvement of heart and kidney function.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR below 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

Children under 18 years of age: The efficacy and safety of dapagliflozin have not been established. There are no relevant data.

Precautions

This medication should not be used in patients who have had allergic reactions to the active ingredient or excipients. It should not be administered to type 1 diabetes patients or patients with diabetic ketoacidosis. This drug contains anhydrous lactose and should not be used in patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. It should also not be administered to patients undergoing dialysis. Careful administration is required in patients with reduced fluid volume or kidney dysfunction, and fluid status and kidney function should be closely monitored before and after administration due to the potential for hypotension or worsening of kidney function. In particular, in patients with moderate to severe kidney function impairment, the glucose control effect may decrease, and it is not recommended for patients with very low kidney function. While taking this medication, there may be an increased risk of genital infections and urinary tract infections; therefore, immediate treatment should be sought if any infection symptoms arise. There is a risk of hypoglycemia; hence, dosage adjustment may be necessary when taken with insulin or insulin secretagogues. Symptoms of dehydration or hypotension may occur due to reduced fluid volume, so special caution is needed for elderly patients or those taking diuretics. Diabetic ketoacidosis may occur, so immediate medical consultation is required if symptoms such as nausea, vomiting, abdominal pain, or shortness of breath appear. It is advisable for pregnant or breastfeeding women to avoid this medication, and it should be discontinued upon confirmation of pregnancy. The safety and efficacy of this drug in pediatric patients have not been established. There is no specific antidote for overdose; appropriate treatment should be provided based on symptoms, and it is unclear whether this drug can be removed by dialysis. This medication has minimal effects on driving or operating machinery, but caution is needed when combined with medications that pose hypoglycemia risks. Store the product out of the reach of children, and keep it in its original container to maintain quality.

Side effects

Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, elevated serum creatinine at the beginning of treatment, increased blood urea, weight loss, acute pyelonephritis, rash, angioedema, urosepsis, pyelitis, acute kidney injury, renal dysfunction, gastroesophageal reflux disease, upper abdominal pain, diverticulosis, bowel perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, paresthesia, cerebral infarction, nerve compression, weakness, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, biliary stones, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chest pain, chest discomfort, edema, foreign body sensation, facial edema, facial pain, heat sensation, flu-like syndrome, breast mass, erectile dysfunction, benign prostatic hyperplasia, mastalgia, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcers, excessive sweating eczema, dyshidrotic eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscular weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, shortness of breath, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 to 30 degrees Celsius at room temperature. This will help preserve the drug's efficacy and prevent degradation.

Appearance and packaging

Appearance

Yellow, biconvex, diamond-shaped film-coated tablet

Package unit

Bottle package - 30 tablets/bottle, bottle package - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.